Ramiro G. Peru, Chairman of the Board of Directors at Elevance Health, Inc. (NYSE:ELV), purchased 1,000 shares of common stock on July 17, 2026. SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($366.05); post-transaction value based on July 17, 2026 market close ($369.16).
How does this purchase affect the director's total equity position?The acquisition of 1,000 shares increases Ramiro G. Peru's direct equity holdings from 9,908 shares to 10,908 shares, reflecting a 10% expansion of his stake in the company.
What is the current market valuation of the director's holdings?Following this transaction, the total direct position is valued at ~$4.03 million based on the July 17, 2026 market close of $369.16.
What was the share price context at the time of the transaction?The purchase was executed at $366.05 per share, while the common stock was priced at $372.85 as of the July 16, 2026 market close, having generated a 22% return over the preceding year as of the transaction date.
What is the broader context of insider ownership at Elevance Health?Following this acquisition, the total beneficial ownership for the reporting director is 10,908 shares, which is an insignificant ownership level of the firm.
Elevance Health operates as a comprehensive health benefits organization offering medical, digital, pharmaceutical, behavioral health, and clinical care solutions to approximately 118 million individuals across consumers, families, and communities.
The company generates revenue through health insurance premiums, managed care services, and integrated healthcare solutions that span the entire health and wellness continuum for its diverse member base.
Elevance Health serves employers, government programs, and individual consumers seeking comprehensive health coverage and wellness solutions across the United States.
Elevance Health is one of the nation's largest health benefits organizations, commanding a significant market position with $201.1 billion in trailing twelve-month (TTM) revenue from serving over 118 million individuals. The company's integrated platform approach—combining medical plans, pharmacy management, behavioral health services, and digital health tools—provides a competitive advantage in delivering coordinated care and managing healthcare costs. Founded in 1944 and headquartered in Indianapolis, Elevance Health demonstrates substantial profitability with $5 billion in TTM net income, reflecting strong operational execution and market leadership in the managed care sector.
Source: Yahoo Finance Top News — This article was automatically imported from the source. Read full article at original source →
